US Filing For AZ’s Imfinzi In Stage III Lung Cancer

Important US filing goes ahead as AstraZeneca submits sBLA for Imfinzi in earlier-stage non-small cell lung cancer.

USA & EU
Imfinzi in Stage III NSCLC is now in the hands of both EU and US regulators • Source: Shutterstock

More from United States

More from North America